
The global AI Imaging and Diagnostics System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI Imaging and Diagnostics System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Imaging and Diagnostics System.
Report Scope
The AI Imaging and Diagnostics System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Imaging and Diagnostics System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Imaging and Diagnostics System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthineers AG
GE Healthcare
IBM Watson Health
Philips Healthcare
AliveCor Inc.
Zebra Medical Vision, Inc.
Riverain Technologies
Vuno, Inc.
Aidoc
Neural Analytics
Imagen Technologies
Digital Diagnostics, Inc.
Google (Subsidiary of Alphabet, Inc.)
Heartflow
Digital Diagnostics (Formerly Known as Idx)
Segment by Type
Hardware
Software
Segment by Application
Hospitals
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Imaging and Diagnostics System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Imaging and Diagnostics System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global AI Imaging and Diagnostics System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Imaging and Diagnostics System Market Perspective (2019-2030)
2.2 AI Imaging and Diagnostics System Growth Trends by Region
2.2.1 Global AI Imaging and Diagnostics System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI Imaging and Diagnostics System Historic Market Size by Region (2019-2024)
2.2.3 AI Imaging and Diagnostics System Forecasted Market Size by Region (2025-2030)
2.3 AI Imaging and Diagnostics System Market Dynamics
2.3.1 AI Imaging and Diagnostics System Industry Trends
2.3.2 AI Imaging and Diagnostics System Market Drivers
2.3.3 AI Imaging and Diagnostics System Market Challenges
2.3.4 AI Imaging and Diagnostics System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Imaging and Diagnostics System Players by Revenue
3.1.1 Global Top AI Imaging and Diagnostics System Players by Revenue (2019-2024)
3.1.2 Global AI Imaging and Diagnostics System Revenue Market Share by Players (2019-2024)
3.2 Global AI Imaging and Diagnostics System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Imaging and Diagnostics System Revenue
3.4 Global AI Imaging and Diagnostics System Market Concentration Ratio
3.4.1 Global AI Imaging and Diagnostics System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Imaging and Diagnostics System Revenue in 2023
3.5 AI Imaging and Diagnostics System Key Players Head office and Area Served
3.6 Key Players AI Imaging and Diagnostics System Product Solution and Service
3.7 Date of Enter into AI Imaging and Diagnostics System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Imaging and Diagnostics System Breakdown Data by Type
4.1 Global AI Imaging and Diagnostics System Historic Market Size by Type (2019-2024)
4.2 Global AI Imaging and Diagnostics System Forecasted Market Size by Type (2025-2030)
5 AI Imaging and Diagnostics System Breakdown Data by Application
5.1 Global AI Imaging and Diagnostics System Historic Market Size by Application (2019-2024)
5.2 Global AI Imaging and Diagnostics System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI Imaging and Diagnostics System Market Size (2019-2030)
6.2 North America AI Imaging and Diagnostics System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI Imaging and Diagnostics System Market Size by Country (2019-2024)
6.4 North America AI Imaging and Diagnostics System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Imaging and Diagnostics System Market Size (2019-2030)
7.2 Europe AI Imaging and Diagnostics System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI Imaging and Diagnostics System Market Size by Country (2019-2024)
7.4 Europe AI Imaging and Diagnostics System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Imaging and Diagnostics System Market Size (2019-2030)
8.2 Asia-Pacific AI Imaging and Diagnostics System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI Imaging and Diagnostics System Market Size by Region (2019-2024)
8.4 Asia-Pacific AI Imaging and Diagnostics System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Imaging and Diagnostics System Market Size (2019-2030)
9.2 Latin America AI Imaging and Diagnostics System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI Imaging and Diagnostics System Market Size by Country (2019-2024)
9.4 Latin America AI Imaging and Diagnostics System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Imaging and Diagnostics System Market Size (2019-2030)
10.2 Middle East & Africa AI Imaging and Diagnostics System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI Imaging and Diagnostics System Market Size by Country (2019-2024)
10.4 Middle East & Africa AI Imaging and Diagnostics System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthineers AG
11.1.1 Siemens Healthineers AG Company Detail
11.1.2 Siemens Healthineers AG Business Overview
11.1.3 Siemens Healthineers AG AI Imaging and Diagnostics System Introduction
11.1.4 Siemens Healthineers AG Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.1.5 Siemens Healthineers AG Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare AI Imaging and Diagnostics System Introduction
11.2.4 GE Healthcare Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 IBM Watson Health
11.3.1 IBM Watson Health Company Detail
11.3.2 IBM Watson Health Business Overview
11.3.3 IBM Watson Health AI Imaging and Diagnostics System Introduction
11.3.4 IBM Watson Health Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.3.5 IBM Watson Health Recent Development
11.4 Philips Healthcare
11.4.1 Philips Healthcare Company Detail
11.4.2 Philips Healthcare Business Overview
11.4.3 Philips Healthcare AI Imaging and Diagnostics System Introduction
11.4.4 Philips Healthcare Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.4.5 Philips Healthcare Recent Development
11.5 AliveCor Inc.
11.5.1 AliveCor Inc. Company Detail
11.5.2 AliveCor Inc. Business Overview
11.5.3 AliveCor Inc. AI Imaging and Diagnostics System Introduction
11.5.4 AliveCor Inc. Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.5.5 AliveCor Inc. Recent Development
11.6 Zebra Medical Vision, Inc.
11.6.1 Zebra Medical Vision, Inc. Company Detail
11.6.2 Zebra Medical Vision, Inc. Business Overview
11.6.3 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Introduction
11.6.4 Zebra Medical Vision, Inc. Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.6.5 Zebra Medical Vision, Inc. Recent Development
11.7 Riverain Technologies
11.7.1 Riverain Technologies Company Detail
11.7.2 Riverain Technologies Business Overview
11.7.3 Riverain Technologies AI Imaging and Diagnostics System Introduction
11.7.4 Riverain Technologies Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.7.5 Riverain Technologies Recent Development
11.8 Vuno, Inc.
11.8.1 Vuno, Inc. Company Detail
11.8.2 Vuno, Inc. Business Overview
11.8.3 Vuno, Inc. AI Imaging and Diagnostics System Introduction
11.8.4 Vuno, Inc. Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.8.5 Vuno, Inc. Recent Development
11.9 Aidoc
11.9.1 Aidoc Company Detail
11.9.2 Aidoc Business Overview
11.9.3 Aidoc AI Imaging and Diagnostics System Introduction
11.9.4 Aidoc Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.9.5 Aidoc Recent Development
11.10 Neural Analytics
11.10.1 Neural Analytics Company Detail
11.10.2 Neural Analytics Business Overview
11.10.3 Neural Analytics AI Imaging and Diagnostics System Introduction
11.10.4 Neural Analytics Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.10.5 Neural Analytics Recent Development
11.11 Imagen Technologies
11.11.1 Imagen Technologies Company Detail
11.11.2 Imagen Technologies Business Overview
11.11.3 Imagen Technologies AI Imaging and Diagnostics System Introduction
11.11.4 Imagen Technologies Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.11.5 Imagen Technologies Recent Development
11.12 Digital Diagnostics, Inc.
11.12.1 Digital Diagnostics, Inc. Company Detail
11.12.2 Digital Diagnostics, Inc. Business Overview
11.12.3 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Introduction
11.12.4 Digital Diagnostics, Inc. Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.12.5 Digital Diagnostics, Inc. Recent Development
11.13 Google (Subsidiary of Alphabet, Inc.)
11.13.1 Google (Subsidiary of Alphabet, Inc.) Company Detail
11.13.2 Google (Subsidiary of Alphabet, Inc.) Business Overview
11.13.3 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Introduction
11.13.4 Google (Subsidiary of Alphabet, Inc.) Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.13.5 Google (Subsidiary of Alphabet, Inc.) Recent Development
11.14 Heartflow
11.14.1 Heartflow Company Detail
11.14.2 Heartflow Business Overview
11.14.3 Heartflow AI Imaging and Diagnostics System Introduction
11.14.4 Heartflow Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.14.5 Heartflow Recent Development
11.15 Digital Diagnostics (Formerly Known as Idx)
11.15.1 Digital Diagnostics (Formerly Known as Idx) Company Detail
11.15.2 Digital Diagnostics (Formerly Known as Idx) Business Overview
11.15.3 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Introduction
11.15.4 Digital Diagnostics (Formerly Known as Idx) Revenue in AI Imaging and Diagnostics System Business (2019-2024)
11.15.5 Digital Diagnostics (Formerly Known as Idx) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Siemens Healthineers AG
GE Healthcare
IBM Watson Health
Philips Healthcare
AliveCor Inc.
Zebra Medical Vision, Inc.
Riverain Technologies
Vuno, Inc.
Aidoc
Neural Analytics
Imagen Technologies
Digital Diagnostics, Inc.
Google (Subsidiary of Alphabet, Inc.)
Heartflow
Digital Diagnostics (Formerly Known as Idx)
Ìý
Ìý
*If Applicable.
